10-Q: Northern Technologies International Corporation Reports Increased Profitability in Q1 2024

Northern Technologies International Corporation (NTIC) saw a rise in net income and a slight increase in sales for the first quarter of fiscal year 2024, compared to the same period last year.

Summary

• Northern Technologies International Corporation (NTIC) reported a net income attributable to NTIC of $895,521, or $0.09 per diluted share, for the three months ended November 30, 2023, compared to $502,242, or $0.05 per diluted share, for the same period in 2022.
• The company's net sales increased by 1.1% to $20,181,675, driven primarily by a rise in Natur-Tec product sales.
• Cost of goods sold decreased to 63.7% of net sales, down from 68.2% in the prior year, due to lower raw material prices.
• Equity in income from joint ventures decreased by 7.3% to $1,102,241, mainly due to lower income from the German joint venture, EXCOR.
• Total operating expenses increased by 5.2% to $8,309,040, primarily due to higher personnel costs.
• The company's cash and cash equivalents stood at $6,094,032 as of November 30, 2023, compared to $5,406,173 as of August 31, 2023.
• NTIC's working capital was $22,415,145 as of November 30, 2023, compared to $22,950,184 as of August 31, 2023.

Sentiment

Score: 7

Explanation: The document shows positive financial results with increased profitability and sales, but also highlights some challenges and risks, resulting in a moderately positive sentiment.

Positives

• The company experienced a significant increase in net income attributable to NTIC.
• Gross profit increased due to lower raw material costs.
• Net sales saw a slight increase, driven by growth in Natur-Tec products.
• Operating income increased year over year.
• The company maintained its dividend payout at $0.07 per share.

Negatives

• Equity in income from joint ventures decreased by 7.3% due to lower income from the German joint venture.
• Total operating expenses increased by 5.2% due to higher personnel costs.
• Net sales of ZERUST oil and gas products decreased by 7.4% due to timing of deliveries.
• Joint venture net sales decreased by 4.7% due to decreased demand at the German joint venture.

Risks

• The company is exposed to fluctuations in foreign currency exchange rates, which could impact reported net income.
• Commodity price changes, particularly in plastic and bioplastic resins, pose a risk to the company's cost of goods sold.
• The company's sales in the oil and gas industry are subject to volatility and long sales cycles.
• The company's earnings are subject to quarterly fluctuations due to the performance of subsidiaries and joint ventures.
• The company is exposed to risks associated with international operations, including import duties, taxes, and tariffs.
• The company is dependent on the success of its joint ventures and the fees and dividend distributions it receives from them.
• The company is exposed to risks associated with the ongoing war between Russia and Ukraine, and the effect of the war and the resulting sanctions by U.S. and European governments on commodity price fluctuations.

Future Outlook

NTIC expects to continue investing in Zerust India, NTIC China, NTI Europe, its joint ventures, research and development, marketing efforts, and its Natur-Tec bio-plastics business. The company also anticipates that its quarterly net income will continue to remain subject to significant volatility.

Management Comments

• NTIC's management believes that a combination of existing cash, forecasted cash flows, and available financing will be adequate to fund operations for at least the next 12 months.
• Management anticipates that its earnings will continue to be adversely affected to some extent by inflation and worldwide supply chain disruptions.
• Management considers the earnings of certain foreign joint ventures to be indefinitely invested outside the United States.

Industry Context

NTIC operates in the corrosion prevention and bioplastics industries, which are influenced by global economic conditions, supply chain dynamics, and environmental regulations. The company's focus on the oil and gas industry aligns with the need for corrosion prevention in critical infrastructure, while its Natur-Tec products cater to the growing demand for sustainable alternatives to traditional plastics.

Comparison to Industry Standards

• NTIC's gross margin of 36.3% is within the range of other specialty chemical and materials companies, but is lower than some of the larger players in the industry.
• The company's reliance on joint ventures for international expansion is a common strategy in the industry, but it also introduces additional risks and complexities.
• NTIC's focus on both corrosion prevention and bioplastics provides diversification, which is a positive factor compared to companies focused on a single product line.
• Compared to companies like Cortec Corporation in the corrosion prevention space, NTIC has a broader international reach through its joint venture network.
• In the bioplastics sector, NTIC competes with companies like NatureWorks and Novamont, but focuses on compostable resins and finished products.

Stakeholder Impact

• Shareholders will benefit from the increased profitability and the continued dividend payout.
• Employees may see increased job security and potential for growth due to the company's expansion efforts.
• Customers will continue to have access to NTIC's products and services.
• Suppliers will continue to have business with NTIC.
• Creditors will be reassured by the company's strong financial position and ability to meet its obligations.

Next Steps

• NTIC expects to continue investing in Zerust India, NTIC China, NTI Europe, its joint ventures, research and development, marketing efforts, and its Natur-Tec bio-plastics business.
• The company will continue to transition some of its joint ventures as needed or appropriate.
• NTIC anticipates that its quarterly net income will continue to remain subject to significant volatility.

Key Dates

Keywords

ZERUST, Natur-Tec, corrosion prevention, bioplastics, joint ventures, net income, net sales, operating expenses, financial results, quarterly report